Header cover image

Chinese (SSE) Healthcare Sector Analysis

UpdatedJul 17, 2025
DataAggregated Company Financials
Companies466
  • 7D3.3%
  • 3M13.1%
  • 1Y21.6%
  • YTD14.6%

The Healthcare industry is up 2.7% in the last week, with WuXi AppTec up 13%. Meanwhile, Qianjiang Yongan Pharmaceutical actually underperformed within the industry, shrinking 17% in the last week. In the last 12 months, the industry was up 22%. Earnings are forecast to grow by 22% annually.

Sector Valuation and Performance

Has the Chinese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 17 Jul 2025CN¥6.3tCN¥2.2tCN¥150.0b37.4x41.8x2.9x
Sat, 14 Jun 2025CN¥6.1tCN¥2.2tCN¥150.0b35.5x40.6x2.8x
Mon, 12 May 2025CN¥5.6tCN¥2.2tCN¥149.6b33.8x37.6x2.6x
Wed, 09 Apr 2025CN¥5.4tCN¥2.2tCN¥158.8b30.1x33.9x2.4x
Fri, 07 Mar 2025CN¥5.8tCN¥2.2tCN¥153.7b32.8x37.4x2.6x
Sun, 02 Feb 2025CN¥5.4tCN¥2.2tCN¥153.8b30.9x34.9x2.4x
Tue, 31 Dec 2024CN¥5.7tCN¥2.2tCN¥153.7b32x36.9x2.5x
Thu, 28 Nov 2024CN¥5.9tCN¥2.2tCN¥154.1b33.6x38.2x2.6x
Sat, 26 Oct 2024CN¥5.9tCN¥2.3tCN¥161.9b32.4x36.5x2.6x
Mon, 23 Sep 2024CN¥4.7tCN¥2.2tCN¥161.8b26.4x29.2x2.1x
Wed, 21 Aug 2024CN¥5.0tCN¥2.3tCN¥166.0b27.2x30.1x2.2x
Fri, 19 Jul 2024CN¥5.2tCN¥2.3tCN¥166.9b28.4x31.1x2.3x
Sun, 16 Jun 2024CN¥5.5tCN¥2.3tCN¥164.9b29.7x33.2x2.4x
Tue, 14 May 2024CN¥6.0tCN¥2.3tCN¥167.5b32.2x36x2.6x
Thu, 11 Apr 2024CN¥5.7tCN¥2.3tCN¥172.9b29.8x32.8x2.5x
Sat, 09 Mar 2024CN¥5.8tCN¥2.3tCN¥178.9b29.6x32.3x2.5x
Mon, 05 Feb 2024CN¥5.1tCN¥2.3tCN¥177.1b25.9x29x2.2x
Wed, 03 Jan 2024CN¥6.5tCN¥2.3tCN¥176.8b34.9x36.7x2.8x
Fri, 01 Dec 2023CN¥6.7tCN¥2.3tCN¥177.2b36.7x38.1x3x
Sun, 29 Oct 2023CN¥6.4tCN¥2.3tCN¥186.2b33.1x34.3x2.8x
Tue, 26 Sep 2023CN¥6.4tCN¥2.3tCN¥185.2b32.3x34.5x2.8x
Thu, 24 Aug 2023CN¥6.0tCN¥2.3tCN¥192.4b30.3x31.1x2.6x
Sat, 22 Jul 2023CN¥6.5tCN¥2.3tCN¥193.0b33.4x33.6x2.9x
Mon, 19 Jun 2023CN¥6.7tCN¥2.3tCN¥191.7b35.2x35.2x3x
Wed, 17 May 2023CN¥7.0tCN¥2.3tCN¥192.0b35.3x36.4x3.1x
Fri, 14 Apr 2023CN¥7.3tCN¥2.2tCN¥236.4b37.9x31x3.3x
Sun, 12 Mar 2023CN¥7.1tCN¥2.2tCN¥229.9b37.9x30.9x3.2x
Tue, 07 Feb 2023CN¥7.3tCN¥2.2tCN¥233.2b38.3x31.4x3.3x
Thu, 05 Jan 2023CN¥6.9tCN¥2.2tCN¥232.3b36x29.9x3.2x
Sat, 03 Dec 2022CN¥7.0tCN¥2.2tCN¥231.9b37.5x30.3x3.2x
Mon, 31 Oct 2022CN¥6.5tCN¥2.2tCN¥229.8b35.9x28.4x3x
Wed, 28 Sep 2022CN¥6.1tCN¥2.1tCN¥223.5b30.9x27.2x2.9x
Fri, 26 Aug 2022CN¥6.5tCN¥2.1tCN¥229.3b32x28.2x3.1x
Sun, 24 Jul 2022CN¥6.7tCN¥2.1tCN¥225.2b32.8x29.9x3.3x
Price to Earnings Ratio

29.9x


Total Market Cap: CN¥6.7tTotal Earnings: CN¥225.2bTotal Revenue: CN¥2.1tTotal Market Cap vs Earnings and Revenue0%0%0%
Chinese Healthcare Sector Price to Earnings3Y Average 33.6x202320242025
Current Industry PE
  • Investors are optimistic on the Chinese Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 41.4x which is higher than its 3-year average PE of 33.6x.
  • The industry is trading close to its 3-year average PS ratio of 2.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 13% per year over the last three years.
  • Meanwhile revenues for these companies have grown 2.2% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Chinese Healthcare sector?

CN Market0.62%
Healthcare3.30%
Life Sciences6.57%
Healthtech4.05%
Pharma3.75%
Biotech3.73%
Healthcare Services2.37%
Medical Equipment0.96%
Industry PE
  • Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio of 52.2x.
    • Analysts are expecting annual earnings growth of 42.1%, which is higher than its past year's earnings decline of 17.7% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 63% over the next 5 years.
  • This is better than its past earnings decline of 43% per year.
  • In contrast, the Pharma industry is expected to see its earnings grow by 14% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
603259 WuXi AppTecCN¥81.0215.5%
+CN¥31.0b
106.0%PE17.7x
002294 Shenzhen Salubris PharmaceuticalsCN¥53.1517.5%
+CN¥8.8b
87.0%PE98.5x
688166 BrightGene Bio-Medical TechnologyCN¥75.2134.1%
+CN¥8.1b
140.1%PE230.1x
000963 Huadong MedicineCN¥43.9410.3%
+CN¥7.2b
53.4%PE21.6x
688382 InventisBioCN¥42.7737.7%
+CN¥6.8b
480.3%PS146.9x

Latest News